These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
290 related articles for article (PubMed ID: 21670670)
1. Cardiovascular risk factors in inflammatory arthritis. Mirjafari H; Al-Husain A; Bruce IN Curr Opin Lipidol; 2011 Aug; 22(4):296-301. PubMed ID: 21670670 [TBL] [Abstract][Full Text] [Related]
2. Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study. van Halm VP; Nurmohamed MT; Twisk JW; Dijkmans BA; Voskuyl AE Arthritis Res Ther; 2006; 8(5):R151. PubMed ID: 16984661 [TBL] [Abstract][Full Text] [Related]
3. Cardiovascular risk in rheumatoid arthritis: how to lower the risk? van Breukelen-van der Stoep DF; Klop B; van Zeben D; Hazes JM; Castro Cabezas M Atherosclerosis; 2013 Nov; 231(1):163-72. PubMed ID: 24125429 [TBL] [Abstract][Full Text] [Related]
4. Cardiovascular risk in rheumatoid arthritis: effects of anti-TNF drugs. Avouac J; Allanore Y Expert Opin Pharmacother; 2008 May; 9(7):1121-8. PubMed ID: 18422470 [TBL] [Abstract][Full Text] [Related]
5. Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis. Solomon DH; Avorn J; Katz JN; Weinblatt ME; Setoguchi S; Levin R; Schneeweiss S Arthritis Rheum; 2006 Dec; 54(12):3790-8. PubMed ID: 17136752 [TBL] [Abstract][Full Text] [Related]
6. Therapy Insight: managing cardiovascular risk in patients with rheumatoid arthritis. Giles JT; Post W; Blumenthal RS; Bathon JM Nat Clin Pract Rheumatol; 2006 Jun; 2(6):320-9. PubMed ID: 16932711 [TBL] [Abstract][Full Text] [Related]
8. Cardiovascular morbidity and mortality in patients with rheumatoid arthritis: vascular alterations and possible clinical implications. Pieringer H; Pichler M QJM; 2011 Jan; 104(1):13-26. PubMed ID: 21068083 [TBL] [Abstract][Full Text] [Related]
9. Risk factors for cardiovascular disease in rheumatoid arthritis. Gabriel SE; Crowson CS Curr Opin Rheumatol; 2012 Mar; 24(2):171-6. PubMed ID: 22249350 [TBL] [Abstract][Full Text] [Related]
10. Lipid profiles in patients with rheumatoid arthritis: mechanisms and the impact of treatment. Steiner G; Urowitz MB Semin Arthritis Rheum; 2009 Apr; 38(5):372-81. PubMed ID: 18395771 [TBL] [Abstract][Full Text] [Related]
11. Cardiovascular disease in rheumatoid arthritis: disease and treatment interactions and their implications on treatment decisions. Sanders S; Geraci SA J Miss State Med Assoc; 2010 Mar; 51(3):75-80. PubMed ID: 20827876 [TBL] [Abstract][Full Text] [Related]
16. [Chronic inflammation increases the risk of cardiovascular disease in patients with rheumatoid arthritis]. Troelsen LN; Jacobsen S Ugeskr Laeger; 2006 Sep; 168(39):3304-8. PubMed ID: 17032593 [TBL] [Abstract][Full Text] [Related]
17. Atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus. Haque S; Mirjafari H; Bruce IN Curr Opin Lipidol; 2008 Aug; 19(4):338-43. PubMed ID: 18607179 [TBL] [Abstract][Full Text] [Related]
18. Reduction of cardiovascular risk factors with longterm fish oil treatment in early rheumatoid arthritis. Cleland LG; Caughey GE; James MJ; Proudman SM J Rheumatol; 2006 Oct; 33(10):1973-9. PubMed ID: 16881100 [TBL] [Abstract][Full Text] [Related]
19. [Prevention of cardiovascular diseases in rheumatoid arthritis]. Novikova DS; Popkova TV; Nasonov EL Ter Arkh; 2009; 81(5):88-96. PubMed ID: 19537595 [TBL] [Abstract][Full Text] [Related]
20. Are lipid ratios less susceptible to change with systemic inflammation than individual lipid components in patients with rheumatoid arthritis? Toms TE; Panoulas VF; Douglas KM; Nightingale P; Smith JP; Griffiths H; Sattar N; Symmons DP; Kitas GD Angiology; 2011 Feb; 62(2):167-75. PubMed ID: 20682616 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]